BEWICK CRESCENT SURGERY
27 BEWICK CRESCENT, NEWTON AYCLIFFE
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 164 | 170 | 96.5% | |
| STROKE 9 | 2006 | 173 | 197 | 87.8% | |
| Stroke 12 | 2007 | 192 | 206 | 93.2% | |
| Stroke 12 | 2008 | 194 | 211 | 91.9% | |
| Stroke 12 | 2009 | 204 | 223 | 91.5% | |
| Stroke 12 | 2010 | 209 | 227 | 92.1% | |
| STROKE 12 | 2011 | 221 | 243 | 90.9% | |
| STROKE 12 | 2012 | 220 | 241 | 91.3% | |
| STROKE 12 | 2013 | 217 | 240 | 90.4% | |
| STIA007 | 2014 | 229 | 233 | 98.3% | |
| STIA007 | 2015 | 237 | 240 | 98.8% | |
| STIA007 | 2016 | 255 | 259 | 98.5% | |
| STIA007 | 2017 | 261 | 265 | 98.5% | |
| STIA007 | 2018 | 279 | 287 | 97.2% | |
| STIA007 | 2019 | 286 | 291 | 98.3% | |
| STIA007 | 2020 | 301 | 306 | 98.4% | |
| STIA007 | 2021 | 291 | 297 | 98.0% | |
| STIA007 | 2022 | 297 | 297 | 100.0% | |
| STIA007 | 2023 | 296 | 299 | 99.0% |
